Pre- and Post-operative Voice Therapy for Benign Vocal Fold Lesions: Protocol for a Non-randomised, Multicentre feasibility Trial with Embedded Process Evaluation

Overview

Journal Pilot Feasibility Stud

Publisher Biomed Central

Date 2024 May 24

PMID 38783383

Authors

Anna White

Paul Carding

Vicky Booth

Julian McGlashan

Jarrad Van Stan

Pip Logan

Rehab Awad

Affiliations

Soon will be listed here.

Abstract

Background: Management of benign vocal fold lesions (BVFLs) is variable with individuals receiving surgery, voice therapy, or a combination of these approaches. Some evidence suggests that the best outcomes may be achieved when patients are offered pre- and post-operative voice therapy in addition to phonosurgery, but what constitutes pre- and post-operative voice therapy is poorly described. The pre- and post-operative voice therapy (PAPOV) intervention has been developed and described according to the TIDieR checklist and Rehabilitation Treatment Specification System (RTSS) for voice. The PAPOV intervention is delivered by specialist speech and language therapists trained in the intervention and comprises 7 essential and 4 additional components, delivered in voice therapy sessions with patients who are having surgery on their vocal folds for removal of BVFLs.

Study Design: Non-randomised, multicentre feasibility trial with embedded process evaluation.

Method: Forty patients from two sites who are due to undergo phonosurgery will be recruited to receive the PAPOV intervention. Measures of feasibility, including recruitment, retention, and adherence, will be assessed. The feasibility of gathering clinical and cost effectiveness data will be measured pre-treatment, then at 3 and 6 months post-operatively. An embedded process evaluation will be undertaken to explain feasibility findings.

Discussion: This study will assess the feasibility of delivering a described voice therapy intervention protocol to patients who are undergoing surgery for removal of BVFLs. Findings will be used to inform the development and implementation of a subsequent effectiveness trial, should this be feasible.

Trial Registration: This trial has been prospectively registered on ISRCTN (date 4th January 2023), registration number 17438192, and can be viewed here: https://www.isrctn.com/ISRCTN17438192 .

Citing Articles

Correction: Pre‑ and post‑operative voice therapy for benign vocal fold lesions: protocol for a non‑randomised, multicentre feasibility trial with embedded process evaluation.

White A, Carding P, Booth V, McGlashan J, Van Stan J, Logan P Pilot Feasibility Stud. 2024; 10(1):144.

PMID: 39563474 PMC: 11575080. DOI: 10.1186/s40814-024-01572-7.

References

Benninger M . Quality of the voice literature: what is there and what is missing. J Voice. 2011; 25(6):647-52. DOI: 10.1016/j.jvoice.2010.09.005. View

Zhuge P, You H, Wang H, Zhang Y, Du H . An Analysis of the Effects of Voice Therapy on Patients With Early Vocal Fold Polyps. J Voice. 2015; 30(6):698-704. DOI: 10.1016/j.jvoice.2015.08.013. View

Kreiman J, Gerratt B, Kempster G, Erman A, Berke G . Perceptual evaluation of voice quality: review, tutorial, and a framework for future research. J Speech Hear Res. 1993; 36(1):21-40. DOI: 10.1044/jshr.3601.21. View

White A, Awad R, Carding P . Pre and Post-operative Voice Therapy Intervention for Benign Vocal Fold Lesions: A Systematic Review. J Voice. 2021; 37(6):857-874. DOI: 10.1016/j.jvoice.2021.06.005. View

Van Stan J, Whyte J, Duffy J, Barkmeier-Kraemer J, Doyle P, Gherson S . Voice Therapy According to the Rehabilitation Treatment Specification System: Expert Consensus Ingredients and Targets. Am J Speech Lang Pathol. 2021; 30(5):2169-2201. PMC: 8702840. DOI: 10.1044/2021_AJSLP-21-00076. View

Roy N, Merrill R, Thibeault S, Parsa R, Gray S, Smith E . Prevalence of voice disorders in teachers and the general population. J Speech Lang Hear Res. 2004; 47(2):281-93. DOI: 10.1044/1092-4388(2004/023). View

Rosen C, Lee A, Osborne J, Zullo T, Murry T . Development and validation of the voice handicap index-10. Laryngoscope. 2004; 114(9):1549-56. DOI: 10.1097/00005537-200409000-00009. View

Skivington K, Matthews L, Simpson S, Craig P, Baird J, Blazeby J . A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021; 374:n2061. PMC: 8482308. DOI: 10.1136/bmj.n2061. View

Misono S, Yueh B, Stockness A, House M, Marmor S . Minimal Important Difference in Voice Handicap Index-10. JAMA Otolaryngol Head Neck Surg. 2017; 143(11):1098-1103. PMC: 5710355. DOI: 10.1001/jamaoto.2017.1621. View

10.

Belafsky P, Postma G, Koufman J . Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope. 2001; 111(6):979-81. DOI: 10.1097/00005537-200106000-00009. View

11.

Mirza N, Ruiz C, Baum E, Staab J . The prevalence of major psychiatric pathologies in patients with voice disorders. Ear Nose Throat J. 2003; 82(10):808-10, 812, 814. View

12.

Devlin N, Shah K, Feng Y, Mulhern B, van Hout B . Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 2017; 27(1):7-22. PMC: 6680214. DOI: 10.1002/hec.3564. View

13.

Van Stan J, Dijkers M, Whyte J, Hart T, Turkstra L, Zanca J . The Rehabilitation Treatment Specification System: Implications for Improvements in Research Design, Reporting, Replication, and Synthesis. Arch Phys Med Rehabil. 2018; 100(1):146-155. PMC: 6452635. DOI: 10.1016/j.apmr.2018.09.112. View

14.

Walton H, Spector A, Williamson M, Tombor I, Michie S . Developing quality fidelity and engagement measures for complex health interventions. Br J Health Psychol. 2019; 25(1):39-60. PMC: 7004004. DOI: 10.1111/bjhp.12394. View

15.

Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M . Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008; 337:a1655. PMC: 2769032. DOI: 10.1136/bmj.a1655. View

16.

Arffa R, Krishna P, Gartner-Schmidt J, Rosen C . Normative values for the Voice Handicap Index-10. J Voice. 2011; 26(4):462-5. DOI: 10.1016/j.jvoice.2011.04.006. View

17.

Aaen M, Sadolin C, White A, Nouraei R, McGlashan J . Extreme Vocals-A Retrospective Longitudinal study of Vocal Health in 20 Professional Singers Performing and Teaching Rough Vocal Effects. J Voice. 2022; 38(6):1526.e11-1526.e22. DOI: 10.1016/j.jvoice.2022.05.002. View

18.

Cohen S, Kim J, Roy N, Asche C, Courey M . Direct health care costs of laryngeal diseases and disorders. Laryngoscope. 2012; 122(7):1582-8. DOI: 10.1002/lary.23189. View

19.

Toran K, Vaidhya B . Objective voice analysis for vocal polyps following microlaryngeal phonosurgery. Kathmandu Univ Med J (KUMJ). 2011; 8(30):185-9. DOI: 10.3126/kumj.v8i2.3555. View

20.

White A, Carding P . Pre- and Postoperative Voice Therapy for Benign Vocal Fold Lesions: Factors Influencing a Complex Intervention. J Voice. 2020; 36(1):59-67. DOI: 10.1016/j.jvoice.2020.04.004. View